Starting today, Rêve Health members can add GRAIL’s Galleri® test—a first-of-its-kind, clinically validated blood test that detects a shared cancer signal across more than 50 types of cancer—to their personalized wellness journey.
As over 600,000 Americans are expected to lose their lives to cancer in 2025, early detection remains one of the most powerful ways to shift the outcome.
The Galleri® test identifies a unique cancer signal in the bloodstream, often before symptoms appear, enabling proactive intervention for cancers such as pancreatic, ovarian, and esophageal—many of which currently lack routine screening tools.
“At Rêve Health, we believe prevention is only part of the equation—true health also requires meaning, balance, and insight,” said Rêve Health Co-Founder and CEO Julie Elaine Brown.
“By offering the Galleri test alongside our comprehensive lab panel, Eastern diagnostic principles, and guidance on life purpose, we are empowering our members to take control of their health from every angle: physical, energetic, and emotional.”
Rêve Health’s members receive personalized reports and guidance combining a root-cause approach of ancient wisdom with advanced biomarker labs and the latest proactive science. For members who add on the Grail Galleri test, we provide a holistic based assessment and the potential to work alongside our team and your physician for an integrative approach for additional care as needed.
“We can offer something truly transformative: a system of care that not only heals your body but helps maintain its balance. These insights are interpreted through both Western medical frameworks and time-tested practices from Traditional Chinese Medicine, offering a 360° view of the body’s current state and future risks,” said Rêve Health Co-Founder and COO Madeline Cunningham, L.Ac.
Through its unique model, Rêve Health equips members with data-driven tools and expert coaching from board certified professionals to uncover hidden imbalances before they become disease—and to align health choices with their deepest values.
The addition of the innovative and next-gen GRAIL Galleri testing enables members to screen for cancers that silently develop without symptoms, helping to catch disease in its earliest and most treatable stages.
This offering marks the latest innovation in Rêve Health mission to redefine optimal health. The company recently expanded its practitioner-guided programs across ten states in the U.S. and plans to launch a new digital TCM assessment tool later this year to help decode symptoms through the lens of energy flow, organ patterns, and elemental imbalances.
About Rêve Health
Rêve Health is the first precision health platform to integrate biomarker testing, Traditional Chinese Medicine, and purpose-aligned living. Members receive over 100 advanced lab tests, personalized health coaching, and tools to uncover the root causes of imbalance and disease. By combining modern diagnostics with ancient wisdom, Rêve Health helps individuals optimize their physical health, emotional resilience, and life direction—all through one personalized, proactive system. At Rêve Health, we’re not just talking about the future of wellness—we’re actively shaping it. For more information, visit www.revehealth.com.
About the Galleri Test
The Grail Galleri® test screens for cancer before symptoms appear. Aggressive cancers can develop quickly and without symptoms. Cancers growing in the body shed DNA into the bloodstream, the DNA fragments can act like a unique “fingerprint” of cancer. The Galleri® test may be able to detect such a “fingerprint” before a clinical diagnosis through conventional means. Please visit Galleri.com for more information: https://www.galleri.com/what-is-galleri
